CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tcm Biotech International Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tcm Biotech International Corp
7F, No. 11, Lane 35,
Jihu Road, Neihu District
Phone: +886 226972628p:+886 226972628 NEW TAIPEI, 221  Taiwan Ticker: 41694169
Business Summary
TCM BIOTECH INTERNATIONAL CORP. is a Taiwan-based company principally engaged in the detection and development of new medicine for liver disease. The Company’s main businesses include the development of new medicine, which are mainly used for the treatment of hepatitis C and non-alcoholic fatty liver and other disease, manufacture and sales of dietary supplements and botanical raw materials, the sales of western medicine products and medical equipment, which are mainly used for the treatment of orthopedic disorders, cardiovascular disorders, oncology disorders and others, sales agent of organic products. The Company distributes its products both in domestic markets and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5047 Medical, dental, and hospital equipment and supplies
5149 Groceries and related products, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HuanqingXu 4/1/2015 6/23/2010
Chief Financial Officer XiumingWei 8/10/2023 8/10/2023
General Manager, Director YajunWang 4/1/2015 5/23/2011
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 73 (As of 12/31/2012)
Outstanding Shares: 59,048,000 (As of 6/30/2024)
Shareholders: 1,834
Stock Exchange: TPO
Fax Number: +886 226972627


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024